Kristin Hodous | Senior Manager-Investor Relations |
Jeff Albers | Chief Executive Officer |
Christy Rossi | Chief Commercial Officer |
Becker Hewes | Chief Medical Officer |
Mike Landsittel | Chief Financial Officer |
Salveen Richter | Goldman Sachs |
Marc Frahm | Cowen |
Dane Leone | Raymond James |
Reni Benjamin | JMP Securities |
Peter Lawson | Barclays |
David Lebowitz | Morgan Stanley |
Benjamin Kallo | Baird |
Michael Schmidt | Guggenheim Partners |
Andrew Berens | SVB Leerink |
Arlinda Lee | Canaccord |
Good morning everyone. My name is Seth, and I will be your conference operator for today. At this time, I would like to welcome everyone to the Blueprint Medicines Second Quarter 2021 Financial Results Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session.